UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 9, 2022 5:00 P.M.
Form:
S-3
CIK:
0001807120
Company Name:
Design Therapeutics, Inc.
File Number:
333-264521